AAAAAA
Results:
1-23
|
Results: 23
Authors:
Zollner, B
Feucht, HH
Weitner, L
Adam, A
Schroter, M
Schafer, P
Laufs, R
Citation: B. Zollner et al., Application of HIV-1 genotypic-resistance testing prevents the evolution of further resistance mutations in heavily pretreated patients, J CLIN VIRO, 21(1), 2001, pp. 37-45
Authors:
Zollner, B
Feucht, HH
Schroter, M
Schafer, P
Plettenberg, A
Stoehr, A
Laufs, R
Citation: B. Zollner et al., Primary genotypic resistance of HIV-1 to the fusion inhibitor T-20 in long-term infected patients, AIDS, 15(7), 2001, pp. 935-936
Authors:
Zollner, B
Schafer, P
Feucht, HH
Schroter, M
Petersen, J
Laufs, R
Citation: B. Zollner et al., Correlation of hepatitis B virus load with loss of e antigen and emerging drug-resistant variants during lamivudine therapy, J MED VIROL, 65(4), 2001, pp. 659-663
Authors:
Schafer, P
Tenschert, W
Cremaschi, L
Schroter, M
Zollner, B
Laufs, R
Citation: P. Schafer et al., Area under the viraemia curve versus absolute viral load: Utility for predicting symptomatic cytomegalovirus infections in kidney transplant patients, J MED VIROL, 65(1), 2001, pp. 85-89
Authors:
Schroter, M
Schafer, P
Zollner, B
Polywka, S
Laufs, R
Feucht, HH
Citation: M. Schroter et al., Strategies for reliable diagnosis of hepatitis C infection: The need for aserological confirmatory assay, J MED VIROL, 64(3), 2001, pp. 320-324
Authors:
Zollner, B
Petersen, J
Schroter, M
Laufs, R
Schoder, V
Feucht, HH
Citation: B. Zollner et al., 20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw, LANCET, 357(9260), 2001, pp. 934-935
Authors:
Polywka, S
Schroter, M
Feucht, HH
Zollner, B
Laufs, R
Citation: S. Polywka et al., Relevance of reactivity in commercially available hepatitis C virus antibody assays, J CLIN MICR, 39(4), 2001, pp. 1665-1668
Authors:
Schroter, M
Zollner, B
Schafer, P
Laufs, R
Feucht, HH
Citation: M. Schroter et al., Quantitative detection of hepatitis C virus RNA by light cycler PCR and comparison with two different PCR assays, J CLIN MICR, 39(2), 2001, pp. 765-768
Authors:
Schroter, M
Feucht, HH
Zollner, B
Schafer, P
Laufs, R
Citation: M. Schroter et al., Prevalence of a novel DNA virus (TTV) among patients on maintenance hemodialysis, NEPHRON, 87(2), 2001, pp. 139-142
Authors:
Zollner, B
Stoehr, A
Plettenberg, A
Feucht, HH
Schroter, M
Schafer, P
Laufs, R
Citation: B. Zollner et al., In vivo dynamics and pathogenicity of wild-type and resistant Hepatitis B virus during long-term lamivudine monotherapy - a clinical note, J CLIN VIRO, 17(3), 2000, pp. 183-188
Authors:
Eggers, C
Stuerenburg, HJ
Schafft, T
Zollner, B
Feucht, HH
Stellbrink, HJ
van Lunzen, J
Citation: C. Eggers et al., Rapid clearance of human immunodeficiency virus type 1 from ventricular cerebrospinal fluid during antiretroviral treatment, ANN NEUROL, 47(6), 2000, pp. 816-819
Authors:
Schroter, M
Polywka, S
Zollner, B
Schafer, P
Laufs, R
Feucht, HH
Citation: M. Schroter et al., Detection of TT virus DNA and GB virus type C/hepatitis G virus RNA in serum and breast milk: Determination of mother-to-child transmission, J CLIN MICR, 38(2), 2000, pp. 745-747
Authors:
Fischer, L
Sterneck, M
Zollner, B
Rogiers, X
Citation: L. Fischer et al., Lamivudine improves the prognosis of patients with hepatitis B after livertransplantation, TRANSPLAN P, 32(7), 2000, pp. 2128-2130
Authors:
Feucht, HH
Zollner, B
Schroter, M
Polywka, S
Buggisch, P
Nolte, H
Laufs, R
Citation: Hh. Feucht et al., High rate of chronicity in HCV infection determined by antibody confirmatory assay and PCR in 4110 patients during long-term follow-up, J CLIN VIRO, 13(1-2), 1999, pp. 43-51
Authors:
Schroter, M
Feucht, HH
Zollner, B
Knodler, B
Schafer, P
Fischer, L
Laufs, R
Citation: M. Schroter et al., Prevalence of TTV viremia among healthy subjects and individuals at risk for parenterally transmitted diseases in Germany, HEPATOL RES, 13(3), 1999, pp. 205-211
Authors:
Polywka, S
Schroter, M
Feucht, HH
Zollner, B
Laufs, R
Citation: S. Polywka et al., Low risk of vertical transmission of hepatitis C virus by breast milk, CLIN INF D, 29(5), 1999, pp. 1327-1329
Authors:
Schroter, M
Feucht, HH
Schafer, P
Zollner, B
Laufs, R
Citation: M. Schroter et al., GB virus C hepatitis G virus infection in hemodialysis patients: Determination of seroprevalence by a four-antigen recombinant immunoblot assay, J MED VIROL, 57(3), 1999, pp. 230-234
Authors:
Zollner, B
Feucht, HH
Weitner, L
Adam, A
Laufs, R
Citation: B. Zollner et al., Drug-resistant genotyping in HIV-1 therapy, LANCET, 354(9184), 1999, pp. 1120-1121
Authors:
Schroter, M
Feucht, HH
Schafer, P
Zollner, B
Laufs, R
Citation: M. Schroter et al., Serological determination of hepatitis C virus subtypes 1a, 1b, 2a, 2b, 3a, and 4a by a recombinant immunoblot assay, J CLIN MICR, 37(8), 1999, pp. 2576-2580
Authors:
Feucht, HH
Schroter, M
Zollner, B
Polywka, S
Laufs, R
Citation: Hh. Feucht et al., Age-dependent acquisition of hepatitis G virus GB virus C in a nonrisk population: Detection of the virus by antibodies, J CLIN MICR, 37(5), 1999, pp. 1294-1297
Authors:
Schroter, M
Feucht, HH
Schafer, P
Zollner, B
Polywka, S
Laufs, R
Citation: M. Schroter et al., Definition of false-positive reactions in screening for hepatitis C virus antibodies, J CLIN MICR, 37(1), 1999, pp. 233-234
Authors:
Anastassov, GE
Joos, U
Zollner, B
Citation: Ge. Anastassov et al., Evaluation of the results of delayed rhinoplasty in cleft lip and palate patients - Functional and aesthetic implications and factors that affect successful nasal repair, BR J ORAL M, 36(6), 1998, pp. 416-424
Authors:
Schroter, M
Feucht, HH
Schafer, P
Zollner, B
Laufs, R
Knodler, B
Citation: M. Schroter et al., TT virus viremia and liver transplantation: No significant increase of theprevalence, BLOOD, 92(12), 1998, pp. 4877-4878
Risultati:
1-23
|